Rallybio Corporation
RLYB
$0.298
-$0.0029-0.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.78M | -66.97M | -73.88M | -76.28M | -74.56M |
| Total Depreciation and Amortization | 131.00K | 137.00K | 142.00K | 146.00K | 150.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.62M | 9.05M | 9.30M | 9.39M | 9.87M |
| Change in Net Operating Assets | -258.00K | 6.72M | 10.44M | 9.78M | 4.28M |
| Cash from Operations | -49.28M | -51.07M | -53.99M | -56.96M | -60.27M |
| Capital Expenditure | -- | -12.00K | -12.00K | -12.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.49M | 51.99M | 32.85M | 36.47M | 27.67M |
| Cash from Investing | 33.49M | 51.97M | 32.84M | 36.46M | 27.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.47M | 5.52M | 5.52M | 282.00K | 282.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -268.00K | -269.00K | -258.00K | 0.00 | -139.00K |
| Cash from Financing | 5.20M | 5.25M | 5.26M | 282.00K | 143.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.59M | 6.16M | -15.89M | -20.22M | -32.46M |